MannKind (NASDAQ:MNKD) Now Covered by Wedbush
Wedbush initiated coverage on shares of MannKind (NASDAQ:MNKD – Free Report) in a report published on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $11.00 target price on the biopharmaceutical company’s stock. Several other analysts have also recently weighed in on the company. Wells Fargo & Company began coverage on […]
Wedbush initiated coverage on shares of MannKind (NASDAQ:MNKD – Free Report) in a report published on Monday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $11.00 target price on the biopharmaceutical company’s stock. Several other analysts have also recently weighed in on the company. Wells Fargo & Company began coverage on […]
